As of May 2024 iBio has a market cap of $17.05 Million. This makes iBio the world's 8047th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $17.05 M | 520.72% |
2023 | $2.74 M | -31.34% |
2022 | $4 M | -96.66% |
2021 | $0.11 B | -46.19% |
2020 | $0.22 B | 1536.51% |
2019 | $13.58 M | -4.26% |
2018 | $14.19 M | -30.51% |
2017 | $20.42 M | -41.98% |
2016 | $35.19 M | -18.72% |
2015 | $43.3 M | -12.18% |
2014 | $49.3 M | 128.4% |
2013 | $21.58 M | -27.11% |
2012 | $29.61 M | 10.19% |
2011 | $26.87 M | -73.66% |
2010 | $0.10 B | 301.03% |
2009 | $25.44 M | 933.09% |
2008 | $2.46 M |
On May 18th, 2024 the market cap of iBio was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $372.16 B | 2,182,623.45% | ๐บ๐ธ USA |
Genocea Biosciences
GNCA | $0 M | -99.97% | ๐บ๐ธ USA |
Nektar Therapeutics
NKTR | $0.32 B | 1,790.02% | ๐บ๐ธ USA |
Emergent BioSolutions
EBS | $0.29 B | 1,605.68% | ๐บ๐ธ USA |